Based in Bethlehem, Pennsylvania, OraSure Technologies develops,
manufactures and markets point-of-care, oral fluid specimen collection
devices that leverage proprietary oral fluid technologies, diagnostic
products, including immunoassays and other in vitro diagnostic tests,
and other medical devices.These products include tests for the
detection of antibodies for the HIV virus, including OraQuick
ADVANCE® Rapid HIV-1/2 Antibody Test and the OraSure® HIV-1 Oral
Specimen Collection Device, and oral fluid testing solutions for drugs
of abuse testing, including Intercept® Oral Fluid Drug Testing System
and Q.E.D.® Saliva Alcohol Test.
